Gabriel Scientific in €2.3m Middle East deal
The Irish company behind an infection-resistant range of bedding products is valuing a distribution agreement in the Middle East at US$3 million (€2.3 million).
**Done Deal:** €2.3 million
**The clincher:** "This third deal will see us build our business in the growing Arab health sector. We have invested resources to establish our credentials as key innovators and to capture market share and growth." - *David Woolfson, founder*
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month, €19.99 Monthly thereafter
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team